Clinical Trial Update: Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder [Phase 3]

View source ↗

Summary

This Phase 3 trial assesses the long-term safety and efficacy of imidafenacin in adults with overactive bladder; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Imidafenacin (Imidafenacin)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED